Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07570953
PHASE2/PHASE3

A Study Of Synthetic THC And Sleep

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine if oral dronabinol prior to sleep can improve CPAP adherence and sleep quality in humans. We also seek to determine if combination therapy of CPAP and pre-sleep dronabinol is associated with improved BP regulation. We will also explore BP regulatory mechanisms and whether these are impacted differently between traditional CPAP therapy and combination CPAP/dronabinol.

Official title: Effects Of Nocturnal Dronabinol Use On Obstructive Sleep Apnea Treatment And Physiological Outcomes

Key Details

Gender

All

Age Range

21 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2026-11

Completion Date

2028-04

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

DRUG

Dronabinol

10 mg dose of Dronabinol daily for 6 weeks

DRUG

Placebo

10 mg dose of Placebo daily for 6 weeks

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States